Skip to content

Clinical and molecular genetic aspects of idiopathic epilepsies

Clinical and molecular genetic aspects of idiopathic epilepsies - genetics of idiopathic epilepsies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35523
Enrollment
300
Registered
2009-12-23
Start date
2010-01-31
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy seizures

Interventions

None listed

Sponsors

Epilepsiecentrum Kempenhaeghe
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with a familial history of epilepsy, with multiple (at least 4) family members affected 2. Patients with a severe form of epilepsy with onset in the first year of life in which no acquired cause can be detected. 3. patients with a combination of epilepsy, mental retardation and dysmorphia (=contiguous gene syndrome, probably caused by deletion/duplication of multiple genes and detectable by CGH) 4. Patients on a ketogenic diet with epilepsy of unknown origin Theoretically there are no age restrictions. In case of severe epilepsy with early onset (cfr.2), cases with neonatal onset will also be included, but as DNA diagnostics in a genetic research setting only will be done after all other possible causes are excluded, inclusion in this study in actual practice will only be done after 2 months of life.

Exclusion criteria

Exclusion criteria: Patients in which a acquired cause of epilepsy is suspected (for example perinatal brain damage, lesions visible on MRI,...)

Design outcomes

Primary

MeasureTime frame
In this project we want to 1) describe new genes or loci 2) identify mutations in known epilepsy genes, but in a broader population than the one in which the gene was originally described.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)